Woodline Partners LP Gh Research PLC Call Options Transaction History
Woodline Partners LP
- $17.6 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GHRS
# of Institutions
39Shares Held
38.5MCall Options Held
0Put Options Held
2.6K-
Bvf Inc San Francisco, CA8.83MShares$107 Million4.23% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.68MShares$93.2 Million2.05% of portfolio
-
Lynx1 Capital Management LP San Juan, PR6.75MShares$81.9 Million24.35% of portfolio
-
Rtw Investments, LP New York, NY5.54MShares$67.3 Million1.04% of portfolio
-
Cormorant Asset Management, LP Boston, MA2.01MShares$24.4 Million2.47% of portfolio
About GH Research PLC
- Ticker GHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,020,800
- Market Cap $632M
- Description
- GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...